Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Bahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old

Bahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthBahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old

Bahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old.

View Premium plansBrowse free archive reports